Veterinary Services (United States) — NAICS 54194

An investor's primer. NAICS (North American Industry Classification System) 2022 code 54194 — a five-digit NAICS industry. This is a rollup page; for full detail see the child primer for NAICS 541940.

1. Overview

Veterinary Services is the business of medical care for animals — the clinics, animal hospitals, and testing labs where licensed veterinarians examine, vaccinate, medicate, and operate on pets, horses, and livestock. It is a licensed, local, labor-intensive health-care industry that is largely cash-pay, and one of the most quietly consolidated corners of Main Street. Federal data put industry receipts at roughly $62.8 billion in 2022 across about 34,000 establishments employing roughly 475,000 people [1][2].

For an investor, three features stand out: demand is structurally growing (more pets, owners willing to spend more on them); most care is paid out of pocket at the point of service rather than negotiated down by insurers; and profitable clinics have proven to be attractive, financeable assets — which is why private equity (PE — investment firms that buy companies using pooled capital and debt) and the family-owned candy giant Mars have spent a decade rolling them up.

2. What's inside — and why this level equals its one child

NAICS is a nested system: each five-digit industry contains one or more six-digit national industries. NAICS 54194 contains exactly one child:

Because there is a single child, the five-digit industry (54194) and the six-digit national industry (541940) describe the same set of businesses — the numbers, scope, and economics are identical. This page exists only to sit at the five-digit level of the taxonomy; all the analysis lives in the 541940 primer, which covers scope and exclusions, the investable universe, unit economics, demand drivers, regulation, consolidation, and risks in full. Everything below is a condensed pointer to it.

In brief, 541940 covers establishments of licensed veterinary practitioners providing medicine, dentistry, or surgery for animals, plus veterinary testing laboratories [3]. It excludes non-medical pet care (grooming, boarding, training — NAICS 812910), animal drug and vaccine manufacturing (NAICS 325412, e.g., Zoetis and Elanco plants), and drug distribution (NAICS 424210, e.g., Covetrus, Patterson). Those companies sell into vet clinics but are not in this industry [3].

3. How big it is (this level's rollup figures)

Federal statistics for NAICS 54194 (our ground truth). These come from different surveys and vintages and should not be summed into a single figure:

Because this level equals its one child, these figures match 541940 exactly.

Undercount caveat. County Business Patterns (CBP) counts only employer establishments — it excludes the self-employed, nonemployer businesses, and most government workers — so it misses the tail of sole-proprietor mobile, relief (locum), and house-call vets who operate without payroll [1]. Our stats file provides no nonemployer total, so we do not add one. This industry is not government-dominated (public-health and USDA veterinary activity sit in other classifications), so the undercount is a small nonemployer tail, not a hidden public sector. Note too that employment (475,106) counts all clinic staff — veterinarians, technicians, assistants, receptionists — not just doctors.

The $62.8 billion federal receipts figure covers everything billed by vet establishments — companion-animal, equine, and food-animal medicine, in-clinic product/pharmacy sales, and lab testing. That is why it runs higher than the consumer-facing "vet care" figure the pet industry reports (the American Pet Products Association, APPA, estimated roughly $40 billion spent on veterinary care and clinic product sales, part of ~$158 billion total U.S. pet spending in 2025) [6].

The 2022 national concentration ratios were 22.4% of receipts for the largest 4 firms, 28.2% for the largest 8, 33.2% for the largest 20, and 37.3% for the largest 50 [2]. The Herfindahl-Hirschman Index (HHI, a standard concentration measure) is suppressed in the federal data, so no value is reported [2].

4. Investable universe (where value concentrates)

With only one child industry, there is nothing to weigh across sub-segments — value concentration is exactly as described in the 541940 primer. The short version: there is no large, pure-play, U.S.-listed veterinary-services operator. The clinics that generate the $62.8 billion are owned by private companies and PE funds. Public-market investors therefore mostly buy the ecosystem around the exam table — diagnostics (IDEXX, IDXX), animal-health pharma (Zoetis, ZTS; Elanco, ELAN), pet insurance (Trupanion, TRUP), and retail-plus-clinics (Petco, WOOF; Chewy, CHWY; Tractor Supply, TSCO) — plus one nano-cap pure play (Inspire Veterinary Partners, IVP) and a UK listing (CVS Group, CVSG). The operators themselves — Mars Veterinary Health, JAB's NVA/Ethos, and PE platforms such as Mission Pet Health, VetCor, Thrive, and PetVet — are reached through private markets. See 541940 for the full company and platform tables.

5. How the money works

Vet clinics earn on two revenue streams: professional services (exams, vaccines, surgery, dentistry, imaging, diagnostics, specialty/emergency referrals) and product sales (medications, therapeutic diets, retail). Services are the economic core; products run roughly 10%–26% of practice revenue [5]. The defining feature is that the industry is largely cash-pay: pet insurance covers only about 3.9% of U.S. pets, and even then reimburses the owner rather than negotiating network rates [8]. Clinics therefore set their own prices with no third-party payer clawing them back. The corporate owners make money via the roll-up — buying practices at a multiple of EBITDA (earnings before interest, taxes, depreciation, and amortization), financing largely with debt, then creating value through multiple arbitrage, operating synergy, and organic growth. Full unit economics and benchmarks are in the 541940 primer.

6. Demand drivers

Roughly seven in ten U.S. households own a pet; "humanization" pushes owners toward advanced care; pets are aging and need more lifetime treatment; pet insurance is small but growing fast (U.S. written premium reached $4.74 billion in 2024) [6][8][9]. The U.S. Bureau of Labor Statistics (BLS) projects veterinarian employment to grow 10% from 2024 to 2034 and veterinary technologist/technician employment 9% [10][11]. Vet care is relatively recession-resistant but not immune — APPA reported 22% of owners spent less in 2025 and visit volumes have softened even as prices rose [6]. See 541940 for detail.

7. Regulation

Veterinary medicine is licensed and regulated primarily at the state level (practice acts and boards), with federal overlays on drugs. Key items: Corporate Practice of Veterinary Medicine (CPOM) rules that shape how PE consolidators legally structure ownership; the Veterinarian-Client-Patient Relationship (VCPR) requirement that limits telemedicine and the pharmacy stream; U.S. Drug Enforcement Administration (DEA) registration for controlled substances; and active Federal Trade Commission (FTC) antitrust attention to vet-clinic roll-ups despite modest national concentration . See 541940 for the full treatment.

8. Consolidation

On paper the industry looks fragmented (top-4 firms only 22.4% of revenue, top-50 just 37.3% in 2022) [2], but those national ratios understate reality because veterinary competition is local and consolidation is moving fast. Mars Veterinary Health is the single largest provider of vet care in the country (~2,500 U.S. clinics under Banfield, VCA, and BluePearl), followed by JAB's NVA/Ethos and PE platforms [23][24][26]. Corporate ownership of general practices has climbed from ~8% around 2011 to an estimated quarter-to-half, and to a clear majority in specialty/emergency care [25]. See 541940 for platform footprints.

9. Risks

The main risks (detailed in the 541940 primer): an affordability ceiling as vet-service prices outrun general inflation while visit volumes soften [6][12]; a tight labor market for veterinarians and technicians [10][11]; leverage in the PE roll-up model, with private-credit exposure under scrutiny [25]; regulatory/antitrust friction on consolidation and pricing [29][30]; and gradual pressure on the pharmacy/revenue mix from retail, e-commerce, and telemedicine [20][21]. A relative strength to weigh against these: minimal third-party reimbursement means far less payer/policy risk than human health care.

10. How to invest, and the outlook

Because the operators are mostly private, listed exposure means the ecosystem — diagnostics (IDXX), animal-health pharma (ZTS, ELAN), pet insurance (TRUP), retail-plus-clinics (WOOF, CHWY, TSCO), distributor Patterson (PDCO), the nano-cap pure play IVP, and the UK's CVS Group (CVSG) as the closest at-scale proxy [15][16][17][18][19][20][21][22]. Treat these as a basket of different exposures, not as clinics. Private-market routes (PE funds and platforms, private-credit lending, direct practice ownership, and veterinary real estate) are where the operators actually live [27][30][26]. The long-term tailwind is intact — more pets, willing owners, still-nascent insurance, an aging pet population, BLS-projected employment growth — while the near term is more mixed (soft volumes against a price ceiling, leveraged platforms facing refinancing pressure, cooler deal multiples, more antitrust friction). The plausible eventual event is an initial public offering (IPO) of one of the large private platforms, which would give public investors their first direct, at-scale way to own the clinics themselves.

For the complete analysis, see the child primer: NAICS 541940 Veterinary Services.

---

Sources

1. U.S. Census Bureau, County Business Patterns: 2023, NAICS 541940 (establishments, employment, annual and first-quarter payroll; employer-only coverage). https://data.census.gov/table/CBP2023.CB2300CBP?codeset=naics~54194
2. U.S. Census Bureau, 2022 Economic Census — Concentration of Largest Firms / Selected Statistics, NAICS 541940 (receipts, firms, CR4/CR8/CR20/CR50; HHI suppressed). https://api.census.gov/data/2022/ecnsize/groups/EC2200SIZECONCEN.html
3. U.S. Census Bureau, 2022 NAICS Definition: 541940 Veterinary Services (definition and cross-references/exclusions). https://www.census.gov/naics/?details=541940&year=2022
4. American Veterinary Medical Association (AVMA), Economic State of the Veterinary Profession 2025 (inventory share; per-FTE / per-exam-room / per-hour benchmarks; ownership survey). https://ebusiness.avma.org/files/productdownloads/002_AVMA_SotPReport25_NoPasswordPRO.pdf
5. American Pet Products Association (APPA), U.S. Pet Industry Reaches $158 Billion in 2025 / National Pet Owners Survey (households owning pets; total spend; ~$40B vet care; 22% spent less). https://americanpetproducts.org/news
6. North American Pet Health Insurance Association (NAPHIA), State of the Industry 2025 (penetration 3.9%; ~$4.7B premium). https://naphia.org/news/naphia-news/soi-report-2025/
7. AVMA, US pet insurance industry surpasses $4.7B in 2024, 2025. https://www.avma.org/news/us-pet-insurance-industry-surpasses-4b-2024
8. U.S. Bureau of Labor Statistics, Veterinarians: Occupational Outlook Handbook (10% growth 2024–2034). https://www.bls.gov/ooh/healthcare/veterinarians.htm
9. U.S. Bureau of Labor Statistics, Veterinary Technologists and Technicians: Occupational Outlook Handbook (9% growth 2024–2034). https://www.bls.gov/ooh/healthcare/veterinary-technologists-and-technicians.htm
10. U.S. Bureau of Labor Statistics, Consumer Price Index — Veterinarian Services (long-run ~5%/yr; ~9% in 2022–23), via In2013Dollars. https://www.in2013dollars.com/Veterinarian-services/price-inflation
11. Inspire Veterinary Partners, Inc. (Nasdaq: IVP), Full-Year 2024 results, SEC filings. https://www.stocktitan.net/news/IVP/inspire-veterinary-partners-reports-full-year-2024-financial-dkzbwbe975ji.html
12. U.S. News & World Report, Best Pet Stocks to Watch (Zoetis, IDEXX, Elanco, Trupanion scale snapshot), 2024–2025. https://money.usnews.com/investing/articles/best-pet-stocks
13. IDEXX Laboratories (Nasdaq: IDXX), 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm
14. Zoetis (NYSE: ZTS), 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/1555280/000155528026000011/zts-20251231.htm
15. Trupanion (Nasdaq: TRUP), 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/1371285/000137128526000018/trup-20251231.htm
16. Petco Health and Wellness Company (Nasdaq: WOOF), Form 10-K (FY ending Jan 31, 2026). https://www.sec.gov/Archives/edgar/data/1826470/000119312526106114/woof-20260131.htm
17. Chewy (NYSE: CHWY), Chewy to Acquire Modern Animal, 2026. https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-to-Acquire-Modern-Animal-Accelerating-Evolution-into-a-Fully-Integrated-Healthcare-Ecosystem/default.aspx
18. Tractor Supply Company (Nasdaq: TSCO), Tractor Supply Acquires VIP Petcare Veterinary Services (SEC exhibit), 2026. https://www.sec.gov/Archives/edgar/data/916365/000091636526000046/a5282026tsco-ex991.htm
19. Mars Veterinary Health, Our Companies (Banfield, VCA, BluePearl, AniCura). https://marsveterinary.com/who-we-are/our-companies/
20. Fortune, "Candy maker Mars is the biggest provider of vet care in the country," June 2024. https://fortune.com/2024/06/10/mars-candy-snickers-pet-care-vet-clinics-petsmart-private-equity/
21. PE Reveal, The 10 Largest Corporate-Owned Veterinary Chains in the US, 2024. https://pereveal.substack.com/p/the-10-largest-corporate-owned-veterinary
22. JAB Holding Company / National Veterinary Associates (NVA + Ethos), acquisition and footprint materials. https://www.jabholco.com/documents/6/Press%20release%20NVA%20Acquisition.pdf
23. Mission Pet Health, Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health, 2025. https://missionpethealth.com/2025/07/21/southern-veterinary-partners-and-mission-veterinary-partners-join-together-as-mission-pet-health/
24. VetCor, Our Story / Harvest Partners portfolio (~900 hospitals, U.S. and Canada). https://www.vetcor.com/about-us/our-story
25. Octus, Private-Credit Exposure to Veterinary Rollups… VSOs Under Increasing Pressure, 2025. https://octus.com/resources/articles/private-credit-exposure-to-veterinary-rollups-shows-growing-dispersion-vsos-under-increasing-pressure/
26. AmeriVet, An Overview of Private Equity Investment in Veterinary Services, 2024. https://amerivet.com/blog/veterinary-private-equity
27. Mahan Law / Holland & Hart, Non-Veterinarian Veterinary Practice Ownership Laws by State (CPOM), 2024. https://mahanlaw.com/practice-areas/buying-a-veterinary-practice/non-veterinarian-ownership-by-states/
28. American Animal Hospital Association (AAHA), VCPR and The patchwork quilt of state veterinary telehealth laws, 2024. https://www.aaha.org/vcpr/
29. U.S. Federal Trade Commission, FTC Approves Final Order against JAB Consumer Partners… Rollup of Veterinary Services Clinics, 2022. https://www.ftc.gov/news-events/news/press-releases/2022/10/ftc-approves-final-order-against-jab-consumer-partners-protect-pet-owners-private-equity-firms
30. U.S. Department of Justice, 2023 Merger Guidelines: Overview (serial acquisitions; labor-market competition), 2023. https://www.justice.gov/atr/merger-guidelines/overview
31. American Association of Veterinary State Boards (AAVSB), Practice Act Model, 2026, and AVMA licensing overview. https://www.aavsb.org/wp-content/uploads/2026/03/1_PAM_Model-Documents_2026.pdf